Surovatamig
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Surovatamig, covering 2026-02-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients [Phase 3]